Charles Owen is an applied scientist focused on multi drug resistance Pancreatic cancer , bacterial infection, cell mediated immunity, mast cells and mast cell stabilizers and how they apply to pancreatic cancer. '. Mr. Owen has 2 granted patents. Experienced working with FDA agency, CRO, Academic Institutions. Expert in the chronic pancreatic cancel mediated immune response cascade.and
has identified the first new treatment in 60 years

UNIVERSITY OF TEXAS-MD ANDERSON CANCER CENTER Houston, Texas Professor, Director, – 2014 Division of Cancer Medicine In 2008 I was made the Director of the newly created Translational Chemistry Core Facility at University of Texas – MD Anderson Cancer Center as Professor. My primary responsibility was the design and development of a new proprietary chemotherapeutic agents for the treatment of Pancreatic Cancer.